Patents by Inventor Catherine Aversa Fleener

Catherine Aversa Fleener has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • TREATMENT WITH A BISPECIFIC ANTIBODY THAT BINDS CTLA4 AND PD1
    Publication number: 20230074793
    Abstract: Provided herein, in certain aspects, are methods of treating a cancer in a subject, comprising administering a bispecific anti-CTLA4×anti-PD1 antibody to the subject.
    Type: Application
    Filed: August 5, 2022
    Publication date: March 9, 2023
    Applicant: XENCOR, INC.
    Inventors: Barbara HICKINGBOTTOM, Paul FOSTER, Raphael CLYNES, Ying DING, Lei BAO, Catherine AVERSA-FLEENER
  • Anti-CD86 antibody
    Patent number: 8378082
    Abstract: The present invention discloses a method for assaying the binding of L104EA29YIg to a receptor. The receptor is preferably CD86 or CD80. The present invention also discloses antibodies to be used in the assay, as well as hybridomas expressing the antibodies.
    Type: Grant
    Filed: January 7, 2009
    Date of Patent: February 19, 2013
    Inventors: Catherine Aversa Fleener, Robert M. Townsend, Francisco Leon